Access cutting-edge autism spectrum disorder treatment through this phase 2 clinical trial at a research site in Lexington. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Lexington location
Preparing your pre-screening questions…
Access autism spectrum disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related autism spectrum disorder treatment provided free
Check if you qualify for this autism spectrum disorder clinical trial in Lexington, MA
No-Cost Study Care
Local to Lexington
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Heart rate variability biofeedback (HRVB) is a breathing-based intervention that reduces anxiety in a range of populations. Second-generation wearable HRVB devices not only deliver scheduled biofeedback practice sessions but also allow patients to practice HRVB in-the-moment when it is needed most. This study is testing the acceptability, feasibility, and preliminary efficacy of second-generation, ambulatory HRVB for the treatment of anxiety in autistic youth.
Sponsor: Massachusetts General Hospital
Yes, this clinical trial (NCT07812233) has an active research site in Lexington, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for autism spectrum disorder treatment options in Lexington, MA, this clinical trial (NCT07812233) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lexington research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced autism spectrum disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all autism spectrum disorder clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Lexington — not just this study.
Browse Pulmonary Embolism Trials in Lexington →